Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Metabolomic profile of systemic sclerosis patients.

Murgia F, Svegliati S, Poddighe S, Lussu M, Manzin A, Spadoni T, Fischetti C, Gabrielli A, Atzori L.

Sci Rep. 2018 May 16;8(1):7626. doi: 10.1038/s41598-018-25992-7.

2.

NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis.

Svegliati S, Spadoni T, Moroncini G, Gabrielli A.

Free Radic Biol Med. 2018 Sep;125:90-97. doi: 10.1016/j.freeradbiomed.2018.04.554. Epub 2018 Apr 22. Review.

PMID:
29694853
3.

Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease.

Luchetti MM, Ciccia F, Avellini C, Benfaremo D, Guggino G, Farinelli A, Ciferri M, Rossini M, Svegliati S, Spadoni T, Bolognini L, Fava G, Mosca P, Gesuita R, Skrami E, Triolo G, Gabrielli A.

J Rheumatol. 2018 May;45(5):630-637. doi: 10.3899/jrheum.170833. Epub 2018 Feb 1.

PMID:
29419466
4.

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.

Patrone V, Puglisi E, Cardinali M, Schnitzler TS, Svegliati S, Festa A, Gabrielli A, Morelli L.

Sci Rep. 2017 Nov 1;7(1):14874. doi: 10.1038/s41598-017-14889-6.

5.

Reply.

Luchetti MM, Moroncini G, Svegliati S, Larcher F, Avvedimento EV, Gabrielli A.

Arthritis Rheumatol. 2017 Aug;69(8):1703-1704. doi: 10.1002/art.40138. Epub 2017 Jun 14. No abstract available.

6.

Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

Moroncini G, Cuccioloni M, Mozzicafreddo M, Pozniak KN, Grieco A, Paolini C, Tonnini C, Spadoni T, Svegliati S, Funaro A, Angeletti M, Gabrielli A.

Anal Biochem. 2017 Jul 1;528:26-33. doi: 10.1016/j.ab.2017.04.011. Epub 2017 Apr 24.

PMID:
28450104
7.

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A, Gabrielli A.

Front Immunol. 2017 Apr 12;8:381. doi: 10.3389/fimmu.2017.00381. eCollection 2017.

8.

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A, Gabrielli A.

Front Immunol. 2017 Feb 8;8:75. doi: 10.3389/fimmu.2017.00075. eCollection 2017. Erratum in: Front Immunol. 2017 Apr 12;8:381.

9.

Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.

Fraticelli P, De Vita S, Franzolini N, Svegliati S, Scott CA, Tonnini C, Spadoni T, Gabrielli B, Pomponio G, Moroncini G, Gabrielli A.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S160-7. Epub 2015 Sep 1.

PMID:
26339895
10.

Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.

Moroncini G, Grieco A, Nacci G, Paolini C, Tonnini C, Pozniak KN, Cuccioloni M, Mozzicafreddo M, Svegliati S, Angeletti M, Kazlauskas A, Avvedimento EV, Funaro A, Gabrielli A.

Arthritis Rheumatol. 2015 Jul;67(7):1891-903. doi: 10.1002/art.39125.

11.

Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis.

Svegliati S, Marrone G, Pezone A, Spadoni T, Grieco A, Moroncini G, Grieco D, Vinciguerra M, Agnese S, Jüngel A, Distler O, Musti AM, Gabrielli A, Avvedimento EV.

Sci Signal. 2014 Sep 2;7(341):ra84. doi: 10.1126/scisignal.2004592.

PMID:
25185156
12.

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

Olivieri A, Cimminiello M, Corradini P, Mordini N, Fedele R, Selleri C, Onida F, Patriarca F, Pavone E, Svegliati S, Gabrielli A, Bresciani P, Nuccorini R, Pascale S, Coluzzi S, Pane F, Poloni A, Olivieri J, Leoni P, Bacigalupo A.

Blood. 2013 Dec 12;122(25):4111-8. doi: 10.1182/blood-2013-05-494278. Epub 2013 Oct 23.

13.

Alterations of ROS pathways in scleroderma begin at stem cell level.

Orciani M, Svegliati S, Gorbi S, Spadoni T, Lazzarini R, Regoli F, Di Primio R, Gabrielli A.

J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):211-24.

PMID:
23489700
14.

New insights into the role of oxidative stress in scleroderma fibrosis.

Gabrielli A, Svegliati S, Moroncini G, Amico D.

Open Rheumatol J. 2012;6:87-95. doi: 10.2174/1874312901206010087. Epub 2012 Jun 15.

15.

Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.

Bocchino M, Agnese S, Fagone E, Svegliati S, Grieco D, Vancheri C, Gabrielli A, Sanduzzi A, Avvedimento EV.

PLoS One. 2010 Nov 16;5(11):e14003. doi: 10.1371/journal.pone.0014003.

16.

Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al.

Gabrielli A, Moroncini G, Svegliati S, Avvedimento EV.

Arthritis Rheum. 2009 Nov;60(11):3521-2. doi: 10.1002/art.27209. No abstract available.

17.

Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited.

Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV.

Semin Immunopathol. 2008 Jul;30(3):329-37. doi: 10.1007/s00281-008-0125-4. Epub 2008 Jun 12. Review.

PMID:
18548250
18.

Pathogenic autoantibodies in systemic sclerosis.

Gabrielli A, Svegliati S, Moroncini G, Avvedimento EV.

Curr Opin Immunol. 2007 Dec;19(6):640-5. Review.

PMID:
18083509
19.

Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.

Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV.

Autoimmun Rev. 2007 Dec;7(2):121-6. Epub 2007 Mar 28. Review.

PMID:
18035321
20.

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, Moroncini G, Bacigalupo A, Leoni P, Avvedimento EV, Gabrielli A.

Blood. 2007 Jul 1;110(1):237-41. Epub 2007 Mar 15.

21.

Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts.

Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, Discepoli G, Paterno R, Santillo M, Cuozzo C, Cassano S, Avvedimento EV, Gabrielli A.

J Biol Chem. 2005 Oct 28;280(43):36474-82. Epub 2005 Aug 4.

22.

HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway.

Serù R, Mondola P, Damiano S, Svegliati S, Agnese S, Avvedimento EV, Santillo M.

J Neurochem. 2004 Nov;91(3):613-22.

Supplemental Content

Loading ...
Support Center